| | 144689-24-7 Basic information More.. |
| Product Name: | Olmesartan | | Synonyms: | Olmesartan MedoxomiI Impurity A;Olmesartan EP Impurity A (Olmesartan Acid);5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid;4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid;Olmesartan;4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-(1H-tetazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid;CS 088;RNH 6270 | | CAS: | 144689-24-7 | | MF: | C24H26N6O3 | | MW: | 446.5 | | EINECS: | 646-413-5 | | Mol File: | 144689-24-7.mol |  |
Use
Olmesartan medoxomil, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl-5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (Benicar, Olmetec) uses the tetrazolering system as its acidic system, which participates inreceptor binding.When administered to a patient, the drugis rapidly and completely bioactivated by ester hydrolysis ofthe medoxomil during absorption from the gastrointestinaltract. Once the prodrug is converted to the active form, virtuallyno further metabolism occurs. In September 2007, theFood and Drug Administration (FDA) approved its use as acombination product with the calcium channel blocker amlodipinefor the management of hypertension. This combinationproduct is sold under the tradename of Azor.
- Olmesartan
-
- US $0.00 / Kg
- 2023-04-17
- CAS:144689-24-7
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100ton
- Olmesartan
-
- US $0.00 / KG
- 2021-12-23
- CAS:144689-24-7
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 200kg
- Olmesartan
-
- US $15.00-10.00 / KG
- 2021-07-09
- CAS:144689-24-7
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
|
144689-24-7
Recommend Suppliers |
|